| Literature DB >> 27653632 |
Aleš Gába1, Roman Cuberek2, Zdeněk Svoboda2, František Chmelík2, Jana Pelclová2, Michal Lehnert2, Karel Frömel2.
Abstract
BACKGROUND: To assess the effect of brisk walking on postural stability, bone mineral density (BMD) and body composition in women over 50 years of age with a sedentary occupation.Entities:
Keywords: Body composition; Falls; Obesity; Osteoporosis; Pedometer; Walking intervention
Year: 2016 PMID: 27653632 PMCID: PMC5031336 DOI: 10.1186/s12905-016-0343-1
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
Fig. 1Flowchart of the participant’s recruitment, screening and assessment
Baseline characteristics of the study participants and intervention characteristics
| Intervention group | Control group | |
|---|---|---|
| Age, | 55.9 ± 3.9 | 57.9 ± 5.7 |
| Height, | 163.5 ± 5.5 | 163.4 ± 5.0 |
| Weight, | 69.9 ± 13.0 | 74.3 ± 15.4 |
| BMI, | 26.2 ± 4.7 | 27.8 ± 5.5 |
| Obesitya, | ||
| Normal | 26 (45 %) | 14 (30 %) |
| Overweight | 22 (38 %) | 19 (41 %) |
| Obesity | 10 (17 %) | 13 (29 %) |
| Osteoporosisb, | ||
| Normal BMD | 25 (43 %) | 16 (35 %) |
| Osteopenia | 24 (41 %) | 20 (43 %) |
| Osteoporosis | 9 (16 %) | 10 (22 %) |
| Baseline PA, | 8703 ± 2847 | 9018 ± 3593 |
| Meeting PA recommendation, | ||
| < 5000 steps/day | 5 (9 %) | 6 (13 %) |
| 5000–10,000 steps/day | 36 (62 %) | 26 (57 %) |
| > 10,000 steps/day | 17 (29 %) | 14 (30 %) |
| Length of intervention, | 9.8 ± 1.2 | |
| PA during intervention period, | 11,509 ± 2590 | 9547 ± 2976 |
| Brisk walking intervention, | 4244 ± 764 | |
| Brisk walking/total daily steps ratio | 0.39 ± 0.11 | |
All values are the means ± SDs
BMI body mass index, BMD bone mineral density, PA physical activity
aassessed according to baseline BMI
bassessed according to baseline T-score of the dominant forearm
Change in postural stability, bone mineral density, body weight and composition after a brisk walking intervention
| Intervention group | ∆ | %∆ | Control group | ∆ | %∆ |
|
| |||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Week 10 | Baseline | Week 10 | |||||||
| Postural stability | ||||||||||
| VEO, | 11.4 ± 3.2 | 10.5 ± 2.9 | –0.9* | –7.9 % | 11.6 ± 2.6 | 11.5 ± 2.7 | –0.1 | –0.9 % | 2.73 | 0.102 |
| VEC, | 14.4 ± 4.9 | 14.1 ± 5.6** | –0.3 | –2.1 % | 14.9 ± 4.3 | 18.2 ± 8.9 | 3.3* | 18.1 % | 6.79 | 0.011 |
| VxEO, | 5.2 ± 1.8 | 4.6 ± 2.1 | –0.6 | –11.5 % | 4.6 ± 1.5 | 4.7 ± 2.0 | 0.1 | 2.1 % | 3.32 | 0.071 |
| VxEC, | 6.5 ± 2.9 | 6.4 ± 4.3 | –0.1 | –1.5 % | 5.8 ± 2.7 | 8.3 ± 6.3 | 2.5* | 30.1 % | 4.61 | 0.034 |
| VyEO, | 9.0 ± 2.7 | 8.4 ± 2.3 | –0.6 | –6.7 % | 9.6 ± 2.5 | 9.4 ± 2.3 | –0.2 | –2.1 % | 1.07 | 0.303 |
| VyEC, | 11.4 ± 4.0 | 11.0 ± 3.7** | –0.4 | –3.5 % | 12.4 ± 3.7 | 14.1 ± 5.7 | 1.7* | 12.1 % | 7.41 | 0.008 |
| Bone mineral density | ||||||||||
| Right forearm, | 0.418 ± 0.074 | 0.416 ± 0.072 | –0.002 | –0.5 % | 0.390 ± 0.070 | 0.389 ± 0.069 | –0.001 | –0.3 % | 0.02 | 0.883 |
| Left forearm, | 0.392 ± 0.068 | 0.387 ± 0.063 | –0.005 | –1.3 % | 0.373 ± 0.066 | 0.366 ± 0.068 | –0.007 | –1.9 % | 0.10 | 0.759 |
| Right calcaneus, | 0.494 ± 0.108 | 0.497 ± 0.108 | 0.003 | 0.6 % | 0.527 ± 0.110 | 0.518 ± 0.104 | –0.009 | –1.7 % | 6.16 | 0.015 |
| Left calcaneus, | 0.496 ± 0.103 | 0.507 ± 0.107 | 0.011 | 2.2 % | 0.512 ± 0.099 | 0.516 ± 0.096 | 0.004 | 0.8 % | 1.08 | 0.302 |
| Body weight and composition | ||||||||||
| Body weight, | 69.9 ± 13.0 | 69.4 ± 12.5 | –0.5 | –0.7 % | 74.3 ± 15.4 | 73.9 ± 15.1 | –0.4 | –0.5 % | 0.37 | 0.543 |
| Fat mass, | 24.5 ± 9.3 | 23.7 ± 8.6 | –0.8* | –3.3 % | 27.7 ± 11.5 | 27.0 ± 11.1 | –0.7* | –2.6 % | 0.19 | 0.656 |
| Fat mass, | 34.0 ± 7.1 | 33.2 ± 6.7 | –0.8* | –2.4 % | 35.9 ± 8.1 | 35.2 ± 7.9 | –0.7* | –2.0 % | 0.03 | 0.859 |
| Visceral fat area, | 109.7 ± 35.6 | 105.2 ± 32.8 | –4.5* | –4.1 % | 120.4 ± 40.5 | 116.6 ± 39.6 | –3.8* | –3.3 % | 0.36 | 0.553 |
| Lean body mass, upper limbs, | 4.6 ± 0.8 | 4.6 ± 0.8 | 0.0 | 0 % | 4.9 ± 0.8 | 4.9 ± 0.8 | 0.0 | 0 % | 1.47 | 0.229 |
| Lean body mass, trunk, | 20.3 ± 2.6 | 20.2 ± 2.5 | –0.1 | –0.5 % | 21.0 ± 2.4 | 21.0 ± 2.4 | 0.0 | 0 % | 1.61 | 0.207 |
| Lean body mass, lower limbs, | 13.9 ± 1.8 | 14.0 ± 1.8 | 0.1* | 0.7 % | 14.2 ± 1.9 | 14.4 ± 2.0 | 0.2 | 1.4 % | 0.01 | 0.965 |
All values are the means ± SDs
V mean total COP velocity, Vx mean COP velocity in the medial-lateral direction, Vy mean COP velocity in the anterior-posterior direction, EO eyes opened, EC eyes closed
∆ difference between week 10 and baseline
%∆ percentage difference between week 10 and baseline
*P < 0.01, effect of intervention; LSD post-hoc test after two-way repeated measures ANOVA
**P < 0.01 difference between intervention and control group; LSD post-hoc test after two-way repeated measures ANOVA
Fig. 2Relationship between the percentage difference from the baseline in body weight, fat mass, and visceral fat area and baseline body mass index in the intervention group (N = 58). Note: BMI – body mass index